Clinical Trial Update: Aripiprazole and Prolactin Study [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on aripiprazole assessing prolactin levels in hyperprolactinemia; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperprolactinemia

Drugs mentioned

• Abilify (aripiprazole) (aripiprazole)

Snippet

Sponsor: University of Oxford | Conditions: Hyperprolactinemia | Phase 4 | Status: COMPLETED